Soliris
![Alexion settles Soliris sales practices lawsuit for $125 million](https://pharmtales.com/wp-content/uploads/2023/09/Alexion-settles-Soliris-sales-practices-lawsuit-for-125-million.jpg)
Alexion settles Soliris sales practices lawsuit for $125 million
Anika Sharma
After nearly seven years since the departure of Alexion’s CEO and CFO amidst an investigation into improper sales practices, the ...
![Soliris: EU Approves Breakthrough gMG Treatment for Kids](https://pharmtales.com/wp-content/uploads/2023/07/A-New-Hope-for-Children-and-Teens-with-gMG_-Soliris-Gets-EU-Approval.jpg)
A New Hope for Children and Teens with gMG: Soliris Gets EU Approval
SG Tylor
Source – AstraZeneca The European Union (EU) has granted approval for the expanded use of Soliris (eculizumab) to treat refractory ...
![For the treatment of people with refractory generalized myasthenia gravis, Soliris has received approval in China](https://pharmtales.com/wp-content/uploads/2023/06/For-the-treatment-of-people-with-refractory-generalized-myasthenia-gravis-Soliris-has-received-approval-in-China.jpg)
For the treatment of people with refractory generalized myasthenia gravis, Soliris has received approval in China
SG Tylor
Source- Astrazeneca For the treatment of adult patients with refractory generalized myasthenia gravis (gMG) and anti-acetylcholine receptor (AChR) antibody positivity, ...
![Danicopan Shows Promise as an Add-On to Ultomiris or Soliris, Enhancing Hemoglobin Levels and Disease Control in PNH Patients](https://pharmtales.com/wp-content/uploads/2023/06/Danicopan-Shows-Promise-as-an-Add-On-to-Ultomiris-or-Soliris-Enhancing-Hemoglobin-Levels-and-Disease-Control-in-PNH-Patients-with-Extravascular-Hemolysis-Symptoms.jpg)
Danicopan Shows Promise as an Add-On to Ultomiris or Soliris, Enhancing Hemoglobin Levels and Disease Control in PNH Patients
SG Tylor
Source – AstraZeneca Promising outcomes emerged from the pivotal Phase III ALPHA trial, revealing that danicopan, an investigational oral Factor ...